Several lines of evidence indicate that HO-1 dysregulation is associated with brain inflammation and neurodegeneration, including Parkinson’s and Alzheimer’s diseases. This evidence concerns the gene HMOX1 and early-onset autosomal dominant Alzheimer disease.